Intricate relationship between cancer stemness, metastasis, and drug resistance
MedComm,
Journal Year:
2024,
Volume and Issue:
5(10)
Published: Sept. 21, 2024
Cancer
stem
cells
(CSCs)
are
widely
acknowledged
as
the
drivers
of
tumor
initiation,
epithelial-mesenchymal
transition
(EMT)
progression,
and
metastasis.
Originating
from
both
hematologic
solid
malignancies,
CSCs
exhibit
quiescence,
pluripotency,
self-renewal
akin
to
normal
cells,
thus
orchestrating
heterogeneity
growth.
Through
a
dynamic
interplay
with
microenvironment
(TME)
intricate
signaling
cascades,
undergo
transitions
differentiated
cancer
culminating
in
therapy
resistance
disease
recurrence.
This
review
undertakes
an
in-depth
analysis
multifaceted
mechanisms
underlying
stemness
CSC-mediated
therapy.
Intrinsic
factors
encompassing
TME,
hypoxic
conditions,
oxidative
stress,
alongside
extrinsic
processes
such
drug
efflux
mechanisms,
collectively
contribute
therapeutic
resistance.
An
exploration
into
key
pathways,
including
JAK/STAT,
WNT,
NOTCH,
HEDGEHOG,
sheds
light
on
their
pivotal
roles
sustaining
phenotypes.
Insights
gleaned
preclinical
clinical
studies
hold
promise
refining
discovery
efforts
optimizing
interventions,
especially
chimeric
antigen
receptor
(CAR)-T
cell
therapy,
cytokine-induced
killer
(CIK)
natural
(NK)
cell-mediated
CSC-targeting
others.
Ultimately
use
sorting
single
sequencing
approaches
for
elucidating
fundamental
characteristics
inherent
will
enhance
our
comprehension
CSC
intratumor
heterogeneity,
which
ultimately
would
inform
about
tailored
personalized
interventions.
Language: Английский
Hotspots and trends in gastric cancer stem cell research: a visualization and bibliometric analysis
Jinfeng Liu,
No information about this author
Xiaoxu Han,
No information about this author
Qingyi Wang
No information about this author
et al.
Frontiers in Oncology,
Journal Year:
2025,
Volume and Issue:
15
Published: March 5, 2025
Gastric
cancer
(GC)
is
a
type
of
malignant
tumor
that
seriously
endangers
human
health.
As
the
understanding
mechanisms
underlying
gastric
deepens,
in
recent
years,
investigations
on
stem
cells
(GCSCs)
have
garnered
significant
interest.
They
are
pivotal
onset,
progression,
recurrence,
and
pharmacoresistance
GC.
Comprehensive
research
GCSCs
expected
to
provide
new
strategies
for
diagnosis
treatment
This
article
endeavors
comprehensively
assess
current
status
future
trends
through
bibliometric
analysis,
thereby
providing
valuable
reference
further
-
depth
studies
this
field.
English
language
academic
journals
related
Web
Science
database
were
retrieved.
Subsequently,
VOSviewer
was
utilized
conduct
network
collinear
analysis
exported
source
institutions,
literature
authors,
references,
keywords.
And
CiteSpace
used
perform
statistical
annual
publication
count,
keyword
clustering,
burst.
A
total
3882
documents
met
criteria
incorporated.
The
quantity
published
papers
has
shown
consistent
upward
trend
annually
since
2003.
Among
authors
literature,
multiple
stable
core
author
groups
represented
by
Zhu,
Wei,
Wang,
Mei,
Xu,
Wenrong,
etc.
been
formed.
There
335
associated
institutions
total.
Japan
National
Cancer
Center
strongest
relevance
largest
number
papers.
7
clustering
labels
formed
among
keywords,
including
main
modules
such
as
activation,
cells,
DNA
content
aneuploidy,
expression.
25
burst
keywords
generated,
past
two
years
include
mesenchymal
drug
resistance,
proliferation,
emergence
references
indicates
eight
cited
up
now
focus
research.
overview
30
visually
presented
visual
maps.
In
decade,
scholars'
field
gradually
intensified,
development
good.
Through
deeper
study
mechanism,
intervention
will
be
promising
approach
GC
patients.
hot
topic
still
deserves
more
attention
future.
Language: Английский
Stemness of Cancer: A Study of Triple-negative Breast Cancer From a Neuroscience Perspective
Stem Cell Reviews and Reports,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 12, 2024
Abstract
Stemness,
giving
cancer
cells
massive
plasticity
enabling
them
to
survive
in
dynamic
(e.g.
hypoxic)
environments
and
become
resistant
treatment,
especially
chemotherapy,
is
an
important
property
of
aggressive
tumours.
Here,
we
review
some
essentials
stemness
focusing
on
triple-negative
breast
(TNBC),
the
most
form
all
cancers.
TNBC
express
a
range
genes
mechanisms
associated
with
stemness,
including
fundamental
four
“Yamanaka
factors”.
Most
evidence
concerns
transcription
factor
/
oncogene
c-Myc
interesting
case
expression
neonatal
splice
variant
voltage-gated
sodium
channel
subtype
Nav1.5.
On
whole,
measures
that
reduce
make
less
aggressive,
reducing
their
invasive/metastatic
potential
increasing/restoring
chemosensitivity.
Such
include
gene
silencing
techniques,
epigenetic
therapies
as
well
novel
approaches
like
optogenetics
aiming
modulate
plasma
membrane
voltage.
Indeed,
simply
hyperpolarizing
can
stem
differentiate.
Finally,
give
overview
clinical
aspects
exploitation
cancer/TNBC
diagnostics
therapeutics.
In
particular,
personalised
mRNA-based
mechanistically
meaningful
combinations
are
promising
emerging
discipline
‘cancer
neuroscience’
providing
insights
both
issues
applications.
Graphical
Language: Английский